Robert J Ryan

Title: The Innovations of Robert J. Ryan

Introduction

Robert J. Ryan is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in the development of synthetic peptides. With a total of 2 patents, his work has implications for understanding and treating thyroid-related conditions.

Latest Patents

Robert J. Ryan's latest patents include innovative synthetic peptides derived from the beta-subunit of human thyroid and the alpha-subunit of human glycoprotein hormone. These peptides have been shown to inhibit the binding of 125.sub.I-bTSH to human thyroid. Additionally, peptides corresponding to the regions .alpha.26-46 and .alpha.31-45 have demonstrated potent inhibition of adenylate cyclase activity stimulated by bTSH in a TSH bioassay using FRTL-5 cells. Furthermore, these peptides block the action of thyroid-stimulating immunoglobulin, showcasing their potential therapeutic applications.

Career Highlights

Robert J. Ryan is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research. His work is characterized by a commitment to innovation and a focus on improving medical outcomes through scientific discovery.

Collaborations

Some of his notable coworkers include Daniel J. McCormick and John C. Morris, who contribute to the collaborative environment that fosters innovation at the Mayo Foundation.

Conclusion

Robert J. Ryan's contributions to the field of synthetic peptides and thyroid research highlight his role as a significant inventor. His work not only advances scientific knowledge but also has the potential to impact medical treatments in meaningful ways.